Tags: steatohepatitis
Update on Treatment for Metabolic Dysfunction-Associated Steatohepatitis Cirrhosis
G&H What is the likelihood that a patient with metabolic dysfunction-associated steatohepatitis has cirrhosis? WA The likelihood of cirrhosis depends on which patients with metabolic dysfunction-associated […]
Utilization of Noninvasive Tests to Diagnose At-Risk Metabolic Dysfunction-Associated Steatohepatitis
G&H Why is it important to diagnose at-risk metabolic dysfunction-associated steatohepatitis? MN Metabolic dysfunction-associated steatohepatitis (MASH; formerly known as nonalcoholic steatohepatitis) is prevalent in the United […]
The Gut Microbiome and Nonalcoholic Steatohepatitis
G&H What makes up a healthy microbiome? JS A healthy microbiome is not completely identical in every person. It is influenced by the type of diet, […]
Current Management and Future Treatment of Alcoholic Hepatitis
Abstract: Excessive alcohol consumption is responsible for approximately 50% of all deaths due to cirrhosis. Although the duration and amount of alcohol consumption are the […]
Role of Noninvasive Biomarkers in the Diagnosis of Nonalcoholic Steatohepatitis With Stage 2 or 3 Fibrosis
G&H Why is the stage of fibrosis important in nonalcoholic steatohepatitis? RL Patients with nonalcoholic fatty liver disease (NAFLD) can be divided into 2 broad […]
Diagnosis of Nonalcoholic Steatohepatitis Without Liver Biopsy
G&H What is the relationship between nonalcoholic steatohepatitis and nonalcoholic fatty liver disease, and how common are these conditions? BM Nonalcoholic fatty liver disease (NAFLD) […]
Nonalcoholic Steatohepatitis and Endpoints in Clinical Trials
Abstract: Nonalcoholic fatty liver disease (NAFLD) is now the leading cause of liver disease in developed countries, and the rates of NAFLD continue to rise […]